Aurinia Pharmaceuticals (AUPH) Share-based Compensation (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Aurinia Pharmaceuticals | 2.03 Bn | 1.65 Bn | 71.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112.87% |
| Dec 31, 2025 | 13.67% |
| Sep 30, 2025 | 8.81% |
| Jun 30, 2025 | 259.58% |
| Mar 31, 2025 | -138.11% |
| Dec 31, 2024 | 7.43% |
| Sep 30, 2024 | -3.02% |
| Jun 30, 2024 | 49.66% |
| Mar 31, 2024 | -51.25% |
| Dec 31, 2023 | -0.34% |
| Sep 30, 2023 | -3.75% |
| Jun 30, 2023 | 29.59% |
| Mar 31, 2023 | 37.16% |
| Dec 31, 2022 | -17.04% |
| Sep 30, 2022 | -17.26% |
| Jun 30, 2022 | 43.17% |
| Mar 31, 2022 | -18.12% |
| Dec 31, 2021 | 20.94% |
| Sep 30, 2021 | -8.53% |
| Jun 30, 2021 | -0.87% |
| Mar 31, 2021 | 52.01% |
| Dec 31, 2020 | 11.58% |
| Sep 30, 2020 | 9.73% |
| Jun 30, 2020 | 20.19% |
| Mar 31, 2020 | 91.25% |
| Dec 31, 2019 | -9.59% |
| Sep 30, 2019 | 3.16% |
| Jun 30, 2019 | 22.19% |
| Mar 31, 2019 | 32.13% |
| Dec 31, 2018 | -19.39% |
| Sep 30, 2018 | -25.78% |
| Jun 30, 2018 | -3.88% |
| Mar 31, 2018 | 121.05% |
| Dec 31, 2017 | -10.58% |
| Sep 30, 2017 | 9.20% |
| Jun 30, 2017 | -21.19% |
| Sep 30, 2016 | 265.33% |
| Jun 30, 2016 | -54.41% |
| Sep 30, 2015 | -12.16% |